, , , , , , , , e.a.

The Neuroscience of Depression

Features, Diagnosis, and Treatment

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2021
ISBN13: 9780128179338
Rubricering
Juridisch :
Elsevier Science e druk, 2021 9780128179338
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

The Neuroscience of Depression: Features, Diagnosis and Treatment, is a comprehensive reference to the diagnosis and treatment of depression. This book provides readers with the mechanisms of depression reflecting on the interplay between depression and the biological and psychosocial processes. A detailed introduction to various episodes of depression, from PTSD to post-partum depression is provided, followed by a thorough discussion on biomarkers in depression and how to diagnose depression including the Hamilton Depression Rating scale. This book also includes three full sections on treatment options for depression, including pharmacological, behavioral and other novel regimes. The Neuroscience of Depression: Features, Diagnosis and Treatment is the only resource for researchers and practitioners studying, diagnosis and treating of depression.

Specificaties

ISBN13:9780128179338
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

<p>I. Depression: Introductory Chapters<br>1. Clinical staging in depression<br>2. Neurodevelopmental theory of depression<br>3. Depression after pregnancy <br>4. Modeling maternal depression during pregnancy: Rodent models of Major Depressive Disorder with Peripartum Onset<br>5. Depression in mothers and mental health in children: Impact, risk factors and interventions<br>6. Depression in college students<br>7. Depression in disasters and traumatic events<br>8. Depression and associated Alzheimer s disease<br>9. Comorbidities of depression and Parkinson's disease<br>10. Understanding the relationship between depression and alcohol among students<br>11. Depression in obesity<br>12. Depression and heart rate variability<br>13. Neuroinflammation and depression<br>14. Interlinking antidepressants and the immune system</p> <p>II. Biomarkers and Diagnosis <br>15. Assessment scoring tools of depression<br>16. The Beck Depression Inventory: Uses and applications<br>17. The Hamilton Depression Rating scale: Uses and applications<br>18. The Patient Health Questionnaire (PHQ)<br>19. Screening for Antenatal Depression (AND) using self-report questionnaires: Conceptual issues and measurement limitations<br>20. Edinburgh Postnatal Depression Scale: Description and applicationsJacqueline <br>21. The Death Depression Scale: Description and applications <br>22. Depression Anxiety Stress Scales: Features and Applications <br>23. Arabic version of the two-question Quick Inventory of Depression: Description and applications (QID-2-Ar) <br>24. Depressive Symptoms and Biomarkers of Cardiovascular Disease<br>25. Thioredoxin as an antioxidant protein as a marker in depression<br>26. Methods of neuroimaging in depression: Applications to resting-state functional connectivity <br>27. Neural markers of depression in MRI</p> <p>III. Pharmacological Treatments for Depression<br>28. Angiotensin receptor 1 blockade as an antidepression strategy<br>29. Cannabinoid CB1 receptors and antidepressant effects<br>30. Agomelatine: profiles and applications to depression<br>31. Bumetanide and use in depressive states <br>32. Linking citalopram, serotonin reuptake inhibitors and depressed pregnant women <br>33. Citalopram and usage in sleep-deprivation-induced depression<br>34. Monoaminergic System and Antidepressants<br>35. Duloxetine usage in depression<br>36. Escitalopram and blonanserin as antidepressant agents linking in neurotrophic mechanisms<br>37. Ketamine and the role of (2R,6R)-Hydroxynorketamine in depression<br>38. Linking 5-Hydroxytryptamine, antidepressant actions of (R)-Ketamine and social stress model <br>39. Mirtazapine: Multi-target strategies for treating substance use disorder and depression</p> <p>IV. Counselling, Psychotherapy and Behavioural Treatments for Depression<br>40. Mindfulness-based cognitive therapy and depression <br>41. Online (web based) programs for depression<br>42. Clay art therapy on emotion regulation: Research, theoretical underpinnings, and treatment mechanisms <br>43. Solution-focused counselling: and use in postpartum depression<br>44. Transcranial direct current stimulation (tDCS) combined with cognitive emotional training (CET) as a novel treatment for depression</p> <p>V. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens<br>45. Putative effects of cannabidiol in depression and synaptic plasticity<br>46. Tanscutaneous vagus nerve stimulation in depression<br>47. Exercise for depression as a primary and comorbid with obesity disorder: A narrative<br>48. Acupressure and depression: a scientific narrative<br>49. Potential beneficial effects of Bifidobacterium breve A1 on cognitive impairment and psychiatric disorders <br>50. Coenzyme Q and use in depression <br>51. Gene expression in Major Depressive Disorder: peripheral and brain based studies <br>52. Electroconvulsive therapy for depression: effectiveness, cognitive side-effects and mechanisms of action <br>53. Depression and offspring DNA methylation <br>54. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens: Treating depression with Theta burst stimulation (TBS)</p>

Net verschenen

Rubrieken

    Personen

      Trefwoorden

        The Neuroscience of Depression